MRE-3008F20

CAS: 252979-43-4

Ref. 3D-BM177371

Produktinformation

• Name: MRE-3008F20
• Marke: Biosynth
• Beschreibung: MRE-3008F20 is a diagnostic agent that is used to determine the presence of cardiac or bowel disease in patients. It has also been shown to be effective against autoimmune diseases and cancer tissues, specifically targeting adenosine A3 receptors. MRE-3008F20 binds to these receptors and blocks the action of adenosine, which inhibits the release of substances that cause inflammation and pain. This drug has been shown to inhibit receptor activity in vitro and in vivo, as well as drug transporter function in vitro. MRE-3008F20 also has potent antagonist activity at p2y receptors, which are involved in inflammatory responses. This compound has been shown to have chemotherapeutic properties when used with other drugs such as doxorubicin or gemcitabine for treatment of cancer cells. The thermodynamic data and pharmacokinetic properties for MRE-3008F20 have not yet been determined.

Chemische Eigenschaften

• Molekulargewicht: 432.44 g/mol
• Formel: C₂₁H₂₀N₈O₃
• Reinheit: Min. 95%